Registration Dossier

Administrative data

Endpoint:
relative density
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2015
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Followed USP method, In-house study result.

Data source

Reference
Reference Type:
other: Certificate of Analysis
Title:
Unnamed
Year:
2015
Report Date:
2015

Materials and methods

Test guideline
Qualifier:
according to
Guideline:
other: as per United States Pharmacopeia (USP) test method.
Deviations:
no
GLP compliance:
no
Type of method:
other: USP method

Test material

Reference
Name:
Unnamed
Type:
Constituent
Test material form:
liquid
Details on test material:
No other details on test material were provided.
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Specification No.: SPEC/RDOI/665/1.00
- Purity test date: December 05, 2015.

Results and discussion

Density
Key result
Type:
relative density
Density:
>= 1.592 - <= 1.64 other: unitless
Temp.:
25 °C

Applicant's summary and conclusion

Conclusions:
The in-house study indicates that the relative density (i.e. specific gavity) of the substance 3-bromopyridine is in the range of 1.592 - 1.64 at 25°C using USP method.
Executive summary:

The in-house study indicates that the relative density (i.e. specific gavity) of the substance 3-bromopyridine is in the range of 1.592 - 1.64 at 25°C using USP method.